88 related articles for article (PubMed ID: 6433802)
1. [UFT].
TakuchiT
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1692-6. PubMed ID: 6433802
[No Abstract] [Full Text] [Related]
2. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
3. [Phase I study of orally administered UFT plus l-leucovorin].
Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359
[TBL] [Abstract][Full Text] [Related]
4. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Sanchiz F; Milla A
Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
[TBL] [Abstract][Full Text] [Related]
5. [Report on nationwide pooled data and cohort investigation in UFT phase II study].
Ota K; Taguchi T; Kimura K
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2749-57. PubMed ID: 3115185
[TBL] [Abstract][Full Text] [Related]
6. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
[TBL] [Abstract][Full Text] [Related]
9. [Clinical results of UFT against ovarian carcinoma].
Tanaka K; Kodama S; Nakamura M; Takahashi T; Honma S; Maruhashi T; Tokunaga A; Takeuchi Y; Sudou N; Adachi S
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1229-33. PubMed ID: 8031166
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effect of UFT on bladder cancer].
Asahi T; Matsumura Y; Ozaki Y; Yoshimoto J; Kaneshige T; Kumon H; Tsushima T; Ohmori H
Gan To Kagaku Ryoho; 1982 Mar; 9(3):503-7. PubMed ID: 6820901
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effect of UFT on prostatic cancer].
Naito K; Hisazumi H; Misaki T; Shimada K; Miyazaki K; Kosaka S; Miyagi T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1440-4. PubMed ID: 3925886
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Fujimori S; Kurita H; Azegami T; Koike T; Ohtsuka A; Kobayashi H; Tanaka K; Kurashina K
Gan To Kagaku Ryoho; 2003 May; 30(5):647-52. PubMed ID: 12795096
[TBL] [Abstract][Full Text] [Related]
13. [Cooperative research of UFT E phase II study. Cooperative Study Group of UFT E in Tohoku Area].
Kikuchi K; Wakui A
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2183-90. PubMed ID: 2241182
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of UFT for malignant tumors of urinary organs].
Shida K; Yamanaka H; Ito Y; Shimazaki J; Isaka S; Yokokawa M; Fukui I; Kawai H; Akimoto M; Yoshida K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1307-14. PubMed ID: 6428325
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
[TBL] [Abstract][Full Text] [Related]
16. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
[TBL] [Abstract][Full Text] [Related]
17. [A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration].
Kai K; Endo Y; Yoshida K; Morikawa T; Nobuhisa T; Watanabe T; Matsumoto Y; Yamada T; Doi Y; Nakashima A; Nagahiro W; Ishizuka S; Sato S; Nakashima A; Nabeyama A
Gan To Kagaku Ryoho; 2008 Feb; 35(2):339-41. PubMed ID: 18281779
[TBL] [Abstract][Full Text] [Related]
18. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
Tashiro H; Nomura Y; Ohsaki A
Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
[TBL] [Abstract][Full Text] [Related]
19. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
[TBL] [Abstract][Full Text] [Related]
20. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
